The United States Attorney’s Office for the District of Colorado announced on March 12, 2026, that a 35-year-old Wheat Ridge, Colorado, woman had pleaded guilty to one count of tampering with a consumer product.
According to the plea agreement, the defendant worked as a case management coordinator for a healthcare system and had access to electronic medical records and patients’ personal identifying information. In July 2024, officials at the healthcare system discovered that she had used a patient’s information to pick up a prescription for oxycodone at the in-house pharmacy of a Denver hospital. She replaced the stolen medication with loratadine, an allergy medication.
During further investigation, the defendant admitted to being addicted to opiates. Investigators found that she had picked up approximately 139 prescriptions for about 127 patients between December 2023 and July 2024. She replaced the stolen medications with ibuprofen, aspirin, acetaminophen, and loratadine. Several patients whose prescriptions were tampered with reported significant pain and post-surgical complications because they were unknowingly ingesting the wrong medication.
Compliance Perspective
Issue
Drug diversion or tampering by healthcare staff poses serious risks to patient safety and can constitute abuse, neglect, misappropriation, and criminal conduct. Staff with access to controlled substances or patient information may be able to divert or tamper with medications, making proactive prevention, detection, and response programs critical for every facility. Failure to implement such programs can result in serious harm to patients, legal and regulatory consequences, and potential criminal liability for staff. Facilities should be aware of signs of diversion or tampering, including missing medications, altered or empty vials, unusual behaviors, and improper documentation.
Discussion Points
- Review your policies and procedures for preventing, identifying, and responding to drug diversion or tampering. Ensure procedures clearly outline the steps staff should follow when they suspect or identify tampering. Periodic policy reviews conducted with a compliance or regulatory consultant can help identify gaps and align policies with current best practices.
- Train appropriate staff on preventing, identifying, and responding to suspected drug diversion or tampering. Emphasize the impact on patient safety, the responsibility of staff to report concerns immediately, and the potential legal and regulatory consequences. Med-Net Academy offers the course Drug Diversion: What Every Nursing Facility Needs to Know, which covers commonly abused prescription medications, warning signs of staff substance use disorders, indicators of possible drug diversion, and steps staff can take to prevent and respond to diversion incidents.
- Conduct regular audits of controlled substances to ensure proper documentation and accountability. This should include reconciliation of narcotics logs, verification of medication storage, and monitoring for unusual patterns or discrepancies. Targeted audits, including those performed in coordination with a consultant pharmacist or compliance specialist, can help detect potential diversion or tampering early and reinforce a safe and compliant environment.
*This news alert has been prepared by Med-Net Concepts, Inc. for informational purposes only and is not intended to provide legal advice.*